Antibody-drug conjugates: recent advances in conjugation and linker chemistries.

Tsuchikama K, An Z. · 2018

Read Antibody-drug conjugates: recent advances in conjugation and linker chemistries. by Tsuchikama K, An Z. (2018) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5777969.txt.

Description

Tsuchikama and An review antibody-drug conjugates, cancer drugs that link an antibody to a toxic payload. The antibody guides the payload to cancer cells. That targeting promises stronger effect with less harm to the rest of the body. Two such drugs had won approval, and dozens more were in trials.

The review walks through each part: antibody, payload, and linker. Its main focus is the chemistry that joins them. Old and new conjugation methods are compared. Site specific methods that yield uniform products stand out as a key path. Better chemistry should yield safer, more effective cancer drugs.

Catalog record

CREATORTsuchikama K, An Z.
YEAR2018
COLLECTIONPAPERS
FORMATTXT
FILE SIZE54 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC5777969

Browse the full library · About the Tower of Babel